Medical

1386 views

Pfizer Inc. (NYSE:PFE) Cutting Research Jobs

Pfizer Inc. (NYSE:PFE) is cutting some research jobs at it research center in Cambridge. The drug company has...

1063 views

TRACON Pharmaceuticals Inc (NASDAQ:TCON) Announces Results For Its Combination Drug Trials At Columbia

TRACON Pharmaceuticals Inc (NASDAQ:TCON) announced results from a clinical trial that combined its Inlyta product with TRC105 to...

878 views

Apricus Biosciences Inc (NASDAQ:APRI) Completes Direct Offering Worth $11 Million

Apricus Biosciences Inc (NASDAQ:APRI) completed a direct offering valued at $11 million. The agreement is with Sarissa Capital...

788 views

Second Sight Medical Products Inc (NASDAQ:EYES) Announced It Success In Utilizing Retinal Prosthesis Implants

Second Sight Medical Products Inc (NASDAQ:EYES) announced that is has completed its first successful implants procedure. The three...

1474 views

Biocept Inc (NASDAQ:BIOC) Shows Solid Results In Study At Colombia University

Biocept Inc (NASDAQ:BIOC) made public that its OncoCEE-BR drug in a prospective study performed at Columbus University. The...

1062 views

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Closing On A $10.1 Billion Takeover Deal For Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is closing on a deal to acquire bowel drug maker Salix Pharmaceuticals, Ltd....

832 views

HCA Holdings Inc (NYSE:HCA) Still Healthy Regardless Of Final Supreme Court Rule On Obamacare

HCA Holdings Inc (NYSE:HCA) awaits to see the final verdict from the Supreme Court that is expected to...

1050 views

Stereotaxis Inc (NASDAQ:STXS) Stereotaxis Remote Magnetic Navigation Tops 75,000 Procedures

Stereotaxis Inc (NASDAQ:STXS) announced that it has passed 75,000 procedures using its Stereotaxis remote magnetic navigation technology. The...

1127 views

CorMedix Inc. (NYSEMKT:CRMD) Lead Product, Neutrolin, Gains FDA QIDP Designation

CorMedix Inc. (NYSEMKT:CRMD) announced its lead product, Neutrolin Catheter Lock Solution, has received the Food and Drug Administrations...

799 views

Egalet Corp (NASDAQ:EGLT) Releases Positive Results Of Opiate-Based Pain Reliever, Egalet-100

Egalet Corp (NASDAQ:EGLT) made public the results from its Category 3 human abuse liability study of Egalet-100 showed...